Evidence map›Paper›PMID 40926510›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2025

Ru-Catalyzed Asymmetric Transfer Hydrogenation of α-iminophosphonates: A Novel Synthetic Approach for Valuable Chiral α-Aminophosphonates.

Pierre Plouard, Laura Borrel, Pierre-Olivier Butin, Paul Muller, Rémi Cherpitel, Séverine Loiseau, Ludovic Clarion, David Virieux, Tahar Ayad

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pierre PlouardICGM, Univ, Montpellier, ENSCM, CNRS, Montpellier, France.
Laura BorrelICGM, Univ, Montpellier, ENSCM, CNRS, Montpellier, France.
Pierre-Olivier ButinICGM, Univ, Montpellier, ENSCM, CNRS, Montpellier, France.
Paul MullerICGM, Univ, Montpellier, ENSCM, CNRS, Montpellier, France.
Rémi CherpitelICGM, Univ, Montpellier, ENSCM, CNRS, Montpellier, France.
Séverine LoiseauPhost'in Therapeutics, 104 rue de la galera, 34090, Montpellier, France.
Ludovic ClarionPhost'in Therapeutics, 104 rue de la galera, 34090, Montpellier, France.
David VirieuxICGM, Univ, Montpellier, ENSCM, CNRS, Montpellier, France.ORCID https://orcid.org/0000-0002-6495-9478
Tahar AyadICGM, Univ, Montpellier, ENSCM, CNRS, Montpellier, France.ORCID https://orcid.org/0000-0003-4210-5997

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel Ru-catalyzed asymmetric transfer hydrogenation (ATH) strategy has been developed for the efficient synthesis of valuable chiral α-aminophosphonates from readily available α-iminophosphonates. This method enables the conversion of both acyclic and cyclic substrates in high yields (up to 97%) and excellent enantioselectivities (up to >99:1), providing a practical entry to phosphorus-containing chiral amines. Notably, this is the first reported application of ATH to α-iminophosphonates, offering a robust and operationally convenient alternative to conventional asymmetric hydrogenation (AH) approaches.

Indexed as

asymmetric transfer hydrogenationruthenium catalystα‐Aminophosphonatesα‐Iminophosphonates

Identifiers

PMID40926510
PMCPMC12498074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.